blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3806909

EP3806909 - ENGINEERING EXTRACELLULAR VESICLES FOR AFFINITY PURIFICATION [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  20.10.2023
Database last updated on 25.09.2024
FormerRequest for examination was made
Status updated on  19.03.2021
FormerThe international publication has been made
Status updated on  21.12.2019
Formerunknown
Status updated on  25.06.2019
Most recent event   Tooltip20.10.2023Withdrawal of applicationpublished on 22.11.2023  [2023/47]
Applicant(s)For all designated states
Evox Therapeutics Ltd
Oxford Science Park
Medawar Centre
2nd Floor East Building
Robert Robinson Avenue
Oxford OX4 4HG / GB
[2021/16]
Inventor(s)01 / LLORENTE, Virginia Castilla
Evox Therapeutics Limited Oxford Science Park,
Medawar Centre 2nd Floor East Building, Robert
Robinson Avenue
Oxford Oxfordshire OX4 4HG / GB
02 / LUNDIN, Per
4 William Street Marston
Oxford Oxfordshire OX3 0ER / GB
03 / HEAN, Justin
17 Aldrich Road
Oxford Oxfordshire OX2 7SS / GB
04 / AMIN, Harsh
1 Leas Lane Marcham
Abingdon Oxfordshire OX13 6FT / GB
 [2021/16]
Representative(s)Cooley (UK) LLP
22 Bishopsgate
London EC2N 4BQ / GB
[N/P]
Former [2021/16]Cooley (UK) LLP
Dashwood
69 Old Broad Street
London EC2M 1QS / GB
Application number, filing date19730734.111.06.2019
[2021/16]
WO2019EP65116
Priority number, dateGB2018000962212.06.2018         Original published format: GB 201809622
[2021/16]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019238626
Date:19.12.2019
Language:EN
[2019/51]
Type: A1 Application with search report 
No.:EP3806909
Date:21.04.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 19.12.2019 takes the place of the publication of the European patent application.
[2021/16]
Search report(s)International search report - published on:EP19.12.2019
ClassificationIPC:A61K48/00, C07K14/705, C12N15/88, A61K47/64
[2021/16]
CPC:
C12N15/111 (EP,US); C07K14/705 (EP,US); C12N15/88 (EP,US);
C07K2319/00 (EP); C07K2319/20 (EP); C12N2310/14 (EP,US);
C12N2310/20 (EP,US); C12N2320/32 (EP,US) (-)
C-Set:
C12N2310/531, C12N2310/14 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/16]
TitleGerman:MANIPULATION VON EXTRAZELLULÄREN VESIKELN ZUR AFFINITÄTSREINIGUNG[2021/16]
English:ENGINEERING EXTRACELLULAR VESICLES FOR AFFINITY PURIFICATION[2021/16]
French:INGÉNIERIE DE VÉSICULES EXTRACELLULAIRES POUR UNE PURIFICATION PAR AFFINITÉ[2021/16]
Entry into regional phase11.01.2021National basic fee paid 
11.01.2021Designation fee(s) paid 
11.01.2021Examination fee paid 
Examination procedure11.01.2021Examination requested  [2021/16]
11.01.2021Date on which the examining division has become responsible
02.08.2021Amendment by applicant (claims and/or description)
13.10.2023Application withdrawn by applicant  [2023/47]
Fees paidRenewal fee
14.06.2021Renewal fee patent year 03
31.03.2022Renewal fee patent year 04
22.06.2023Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XI]WO2015002956  (OHIO STATE INNOVATION FOUNDATION [US]) [X] 1-5,8,10,12-16,18-20,22,23,35,36 * abstract * * page 3, line 16 - line 25 * * page 8, line 17 - page 9, line 13 * * page 11, line 1 - line 16 * * page 12, line 11 - line 24 * [I] 6,7,9,11,17,21,24-34;
 [XI]US2015093433  (LEONARD JOSHUA N [US], et al) [X] 1-5,8-10,12-16,18-20,22,23,35,36 * abstract * * page 2, paragraph 25 * * page 3, paragraph 29 * * page 4, paragraphs 36,39 * * page 8, paragraph 68 * [I] 6,7,11,17,21,24-34;
 [Y]US2018015182  (LU BIAO [US], et al) [Y] 1-36 * abstract * * page 1, paragraphs 5,7 * * page 4, paragraphs 35,39 * * page 5, paragraphs 41-46 *;
 [Y]WO2018011191  (EVOX THERAPEUTICS LTD [GB]) [Y] 1-36 * abstract ** page 32 - page 33; claims 1,2,7 *;
 [Y]  - LYDIA ALVAREZ-ERVITI ET AL, "Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes", NATURE BIOTECHNOLOGY, New York, (20110320), vol. 29, no. 4, doi:10.1038/nbt.1807, ISSN 1087-0156, pages 341 - 345, XP055554900 [Y] 1-36 * abstract * * page 341, column r, paragraphs 2,4 * * page 342; figure 1 *

DOI:   http://dx.doi.org/10.1038/nbt.1807
by applicantWO0044389
 WO2014168548
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.